Sagittarius Life Science Corp.(TW:3205)
NT$44.75+-0.50 (+1.70%)
TW:3205
Sagittarius Life Science Corp. financials statements
NT$44.75
At close:+-0.50 (+1.70%)
Sagittarius Life Science Corp. (3205) Income Statement
Sagittarius Life Science Corp. Income Statement
Last quarter (Q2 2026), Sagittarius Life Science Corp.'s total revenue was NT$188.12M, an increase of 66.94% from the same quarter last year. In Q2, Sagittarius Life Science Corp.'s net income was NT$-1.65M. See Sagittarius Life Science Corp.’s key income statements, including revenue, expenses, profit, and income.
| Income Statement | Dec 25 | Dec 24 | Dec 23 | Dec 22 | Dec 21 |
|---|---|---|---|---|---|
| NT$ 346.08M | NT$ 467.75M | NT$ 440.46M | NT$ 529.07M | NT$ 587.61M | |
| NT$ 57.71M | NT$ 81.11M | NT$ 71.48M | NT$ 82.56M | NT$ 100.54M | |
| NT$ 116.22M | NT$ 142.67M | NT$ 135.85M | NT$ 164.79M | NT$ 190.55M | |
| Depreciation and Amortization | NT$ 10.34M | NT$ 14.76M | NT$ 15.03M | NT$ 20.91M | NT$ 24.18M |
| NT$ -48.16M | NT$ -34.72M | NT$ -41.71M | NT$ -55.40M | NT$ -65.92M | |
| NT$ -58.51M | NT$ -61.56M | NT$ -64.38M | NT$ -76.27M | NT$ -87.07M | |
| NT$ 8.63M | NT$ 11.88M | NT$ 7.55M | NT$ -234.00K | NT$ 2.55M | |
| NT$ -49.88M | NT$ -49.68M | NT$ -56.82M | NT$ -76.50M | NT$ -87.46M | |
| NT$ -49.56M | NT$ -48.53M | NT$ -55.04M | NT$ -74.20M | NT$ -86.42M | |
| Per Share Metrics | |||||
| Basic EPS | NT$ -0.92 | NT$ -1.49 | NT$ -1.69 | NT$ -2.28 | NT$ -2.66 |
| Diluted EPS | NT$ -0.92 | NT$ -1.49 | NT$ -1.69 | NT$ -2.28 | NT$ -2.66 |
| Weighted Average Shares Outstanding | 53.87M | 32.62M | 32.55M | 32.55M | 32.55M |
| Weighted Average Shares Outstanding (Diluted) | 53.87M | 32.62M | 32.55M | 32.55M | 32.55M |
Currency in TWD

